Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.
PLoS Negl Trop Dis. 2023 Feb 6;17(2):e0011113. doi: 10.1371/journal.pntd.0011113. eCollection 2023 Feb.
Cholera continues to inflict high rates of morbidity and mortality. Prompt identification of cholera cases facilitates rapid outbreak responses in the short term while providing reliable surveillance data to guide long-term policies and interventions. Microbiological stool culture, the current recognized gold standard for diagnosing cholera, has significant limitations. Rapid diagnostic tests (RDTs) represent promising alternatives for diagnosing cholera in areas with limited laboratory infrastructure. However, studies conducted with the current cholera RDTs demonstrated wide variations in sensitivity and specificity. To address this gap in the diagnosis of cholera, we developed a simple, rapid, and sensitive diagnostic assay, "Rapid LAMP based Diagnostic Test (RLDT)." With a novel, simple sample preparation method directly from the fecal samples along with lyophilized reaction strips and using established Loop-mediated Isothermal Amplification (LAMP) platform, cholera toxin gene (ctxA) and O1 (O1rfb) gene could be detected in less than an hour. Cholera RLDT assay is cold chain and electricity-free. To avoid any end-user bias, a battery-operated, handheld reader was used to read the RLDT results. The performance specifications of the cholera RLDT assay, including analytical sensitivity and specificity, were evaluated using direct fecal samples, dried fecal samples on filter paper, and environmental water samples spiked with cholera strain. The limit of detection (LOD) was ~104 CFU/gm of stool for both ctxA and O1 genes, corresponding to about 1 CFU of Vibrio cholerae per reaction within 40 minutes. The LOD was 10 bacteria per ml of environmental water when tested with RLDT directly, without enrichment. Being simple, RLDT has the potential to be applied in resource-poor endemic settings for rapid, sensitive, and reliable diagnosis of cholera.
霍乱仍然导致高发病率和死亡率。及时发现霍乱病例有助于在短期内迅速做出疫情应对,同时为长期政策和干预措施提供可靠的监测数据。微生物粪便培养是目前公认的霍乱诊断金标准,但存在明显的局限性。快速诊断检测(RDT)为资源有限地区的霍乱诊断提供了有前途的替代方法。然而,使用当前的霍乱 RDT 进行的研究表明,其敏感性和特异性存在广泛差异。为了解决霍乱诊断中的这一差距,我们开发了一种简单、快速、灵敏的诊断检测方法,称为“快速环介导等温扩增诊断检测(RLDT)”。该方法采用新颖、简单的粪便样本直接制备方法,结合冻干反应条,并使用已建立的环介导等温扩增(LAMP)平台,可在不到一小时的时间内检测到霍乱毒素基因(ctxA)和 O1 基因(O1rfb)。霍乱 RLDT 检测不需要冷链和电力。为避免任何终端用户的偏差,我们使用电池供电的手持阅读器读取 RLDT 结果。使用直接粪便样本、滤纸干燥粪便样本和环境水样(用霍乱菌株进行了强化)评估了霍乱 RLDT 检测的性能规格,包括分析灵敏度和特异性。ctxA 和 O1 基因的检测限(LOD)分别约为 104 CFU/gm 粪便和 10 个 CFU/反应,在 40 分钟内。当直接用 RLDT 检测时,环境水样的 LOD 为 10 个细菌/ml,无需富集。由于 RLDT 简单,因此有可能在资源匮乏的流行地区快速、灵敏、可靠地诊断霍乱。